Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count |
| Type de publication | Journal Article |
| Year of Publication | 2020 |
| Auteurs | Divoux M, Plocque A, Sevin M, Voillat L, Feugier P, Guerci-Bresler A, Girodon F, Broseus J |
| Journal | CLINICAL CASE REPORTS |
| Volume | 8 |
| Pagination | 1774-1780 |
| Date Published | SEP |
| Type of Article | Article |
| ISSN | 2050-0904 |
| Mots-clés | lenalidomide, Myelodysplastic Syndrome, myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombosis, myeloproliferative syndrome, thrombocytosis |
| Résumé | Lenalidomide is efficient in reducing red blood cell transfusion dependency and markedly lowering platelet counts in MDS/MPN-RS-T in the context of major platelet counts. |
| DOI | 10.1002/ccr3.3026, Early Access Date = {JUN 2020 |